Molbio becomes second unicorn in Sep with $1.5 Bn valuation
Healthcare diagnostic firm Molbio on Monday announced a $85 million round led by Temasek. The Goa-based firm has now received its first tranche from the Singapore-based investor via V Sciences Investments at a unicorn valuation. It has become the second unicorn in September after Tata 1mg. The online pharmacy entered the $1 billion valuation club in an internal funding round.